-- Molecular Assemblies awarded an additional $4 million to support further technology development in next phase of DARPA-funded project being led by GE HealthCare's Technology and Innovation Center - ...
British drugmaker AstraZeneca is on a mission to lock in as many manufacturing partners as possible to support a planned global rollout for its COVID-19 vaccine front-runner. A New York CDMO has now ...
New raw vaccine materials that could make vaccines more accessible, sustainable, and ethical have been discovered. The results of the research have been published in Polymers. A team of Florida State ...
ZURICH-SCHLIEREN / ACCESSWIRE / September 14, 2020 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company that is developing a new class of custom-built protein drugs known as DARPin® ...
Scientists around the world are focusing their energy and resources on translating advances made in clinical research into relevant biotechnology, clinical, and applied products that improve our ...
“Molecular robots are expected to greatly contribute to the emergence of a new dimension in chemical synthesis, molecular manufacturing, and artificial intelligence,” write Hokkaido University ...
EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics, Inc., (Minute Molecular) today announced it has been awarded a $21.3 million contract from the U.S. National Institutes of Health (NIH) ...
EMERYVILLE, Calif.--(BUSINESS WIRE)--Zymergen, the world’s first molecular manufacturing technology company, announced today it has raised over $400 million in Series C funding led by returning ...
CINCINNATI, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that ...
ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / July 9, 2020 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company that is developing a new class of custom-built proteins known as DARPin ® ...
Almost everything in Chris MacDonald's essay 1 is right. Near-term nanoscale technologies can and should be addressed with the same ethical tools appropriate for other technologies, and should not be ...
Engineered T cell therapies involve the genetic modification of a patient’s own immune cells with chimeric antigen receptors (CARs). When re-introduced into the patient, these engineered CAR-T cells ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback